As vascular smooth muscle cell (VSMC) phenotypic switching has been invariably linked to atherosclerosis, we determined whether genetic ablation or pharmacological inhibition of Nox2 (using the Nox2 inhibitor gp91dstat) had any effect on VSMC phenotype by assessing the expression of heavy chain myosin (HCM). Here, CYBB is linked to atherosclerosis.